The cold and flu viruses that many have avoided while staying at home and social distancing during the COVID-19 pandemic will likely run rampant again as masks come off and schools reopen, reports STAT News.
The Sofia 2 Flu + SARS Antigen FIA point-of-care test delivers three results from one sample in 15 minutes.
The test is designed to speed accurate diagnosis of respiratory infections while enhancing the patient experience.
Protecting sample stability ensures the utility of the latest generation of TB tests.
Read More
The test detects respiratory syncytial virus infection in children and adults, and will be available in physician offices, hospital emergency rooms, and walk-in clinics throughout the United States.
Read More
The company has launched its next-generation wireless rapid diagnostic system for detection of group A Strep, influenza A and B, and respiratory syncytial virus.
Read MoreThe system was specifically developed to enable decentralized sample processing, while the resulting data can be stored and analyzed centrally anywhere in the world.
Read More
The NxTag respiratory panel from Luminex enables laboratories to detect 20 respiratory pathogens simultaneously in a single closed-tube system.
Read MoreCLIA-waived test promises the accuracy of reference laboratory tests for performance at the point of care.
Read MoreThe closed-tube, scalable, 96-well based system from Luminex seeks to meet clinical demand for respiratory disease testing.
Read More
Following best practices can help labs maximize the utility and cost-effectiveness of flu testing.
Read MoreAccording to US Centers for Disease Control and Prevention, a comprehensive and timely overview of influenza activity is an essential public health activity for a variety of reasons.
Read MoreOver time, the American Medical Association has established specific current procedural terminology codes to be used in reporting the results of testing by means of such multiplex molecular pathology panels.
Read MoreWhile viral culture is very sensitive, its long turnaround time, high cost, and requisite skill have made the method obsolete in most laboratories throughout the United States.
Read More
Flexible panel testing is the latest of many advances for the field.
Read More
Developed by Focus Diagnostics, the test is cleared to identify 92 influenza and respiratory syncytial virus strains.
Read More
The Cobas Liat test is the first CLIA-waived real-time polymerase chain reaction test to detect influenza A and B in approximately 20 minutes.
Read More
FDA has granted a Clinical Laboratory Improvement Amendments waiver to the Alere i Influenza A & B test, the only molecular test to detect and differentiate influenza A and B virus in less than 15 minutes, and now the first molecular test to receive a CLIA waiver.
Read More